Securing funding remains one of the biggest challenges for innovative life sciences R&D companies. While venture capital continues to play a critical role, it is important that company leaders look for a broader range of funding options that supports their growth and extends their cash runway.
During this BioTuesday, we will gather a group of speakers to explore the evolving funding landscape, across non-dilutive funding, strategic partnerships, venture debt, translational funding and other routes that can help businesses scale without relying solely on traditional equity investment.
Whether you’re an early-stage start-up or an established SME planning your next phase of growth, this session will provide practical insights into the funding options available, how to identify the right approach for your business, and what funders are looking for in today’s market.